Peter Libby
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 13
- Inflammatory mediators and NSAID effects 13
-
- Atherosclerosis and Cardiovascular Diseases 3
- Co-authors
- Stephen J. C. Warner (1 shared paper)Gary B. Friedman (1 shared paper)Galina K. Sukhova (4 shared papers)Zorina S. Galis (1 shared paper)Richard T. Lee (1 shared paper)Kiyoshi Takayama (2 shared papers)S. Nissen (9 shared papers)A. Michael Lincoff (7 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (2 papers)Journal of the American College of Cardiology (2 papers)European Heart Journal (1 paper)Journal of Lipid Research (1 paper)Circulation Research (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Peter Libby
24 papers receiving 2.3k citations
Peter Libby's Hit Papers
Peers
Comparison fields: 5 of 121
- Pharmacology 659
- Biochemistry 202
- Immunology 490
- Immunology and Allergy 110
- Cardiology and Cardiovascular Medicine 391
Countries citing papers authored by Peter Libby
This map shows the geographic impact of Peter Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Libby more than expected).
Fields of papers citing papers by Peter Libby
This network shows the impact of papers produced by Peter Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Libby. The network helps show where Peter Libby may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Libby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis Hit paper breakdown → | 2016 | 624 |
| 2 | 1988 | 471 | |
| 3 | 1995 | 324 | |
| 4 | 2002 | 299 | |
| 5 | 2009 | 101 | |
| 6 | 2017 | 89 | |
| 7 | 1975 | 79 | |
| 8 | 2011 | 71 | |
| 9 | 2006 | 61 | |
| 10 | 2016 | 48 | |
| 11 | 2017 | 42 | |
| 12 | 2018 | 37 | |
| 13 | 2018 | 34 | |
| 14 | 2014 | 26 | |
| 15 | 2015 | 23 | |
| 16 | 2024 | 22 | |
| 17 | 1999 | 13 | |
| 18 | 2024 | 11 | |
| 19 | 2018 | 7 | |
| 20 | 2024 | 7 |
About Peter Libby
Peter Libby is a scholar working on Pharmacology, Immunology, Immunology and Allergy, Cardiology and Cardiovascular Medicine and Oncology, having authored 24 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (13 papers), Chemokine receptors and signaling (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Cell Adhesion Molecules Research (2 papers), Lipoproteins and Cardiovascular Health (2 papers), NF-κB Signaling Pathways (2 papers), Inflammasome and immune disorders (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Pharmacology (659 citations), Biochemistry (202 citations), Immunology (490 citations), Immunology and Allergy (110 citations) and Cardiology and Cardiovascular Medicine (391 citations). Peter Libby has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Stephen J. C. Warner, Gary B. Friedman, Galina K. Sukhova, Zorina S. Galis, Richard T. Lee, Kiyoshi Takayama, S. Nissen, A. Michael Lincoff, Neville D. Yeomans and M. Elaine Husni. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Journal of the American College of Cardiology, European Heart Journal, Journal of Lipid Research and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.